Skip to main content
Abstract A003: The clinical impact of targeted next-generation sequencing for advanced pediatric and AYA sarcoma patients in the iCat2/GAIN Consortium Study.
Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma.
Abstract A014 INO80-complex N-terminal module resolves replication stress in PAX3-FOXO1 positive rhabdomyosarcoma and exposes therapeutic vulnerability.
Abstract 2862: Evolution of clinically relevant variants in advanced pediatric sarcomas.
Abstract 138: UCHL5 and PAX3-FOXO1 resolve replication stress in rhabdomyosarcoma.
Abstract 1759: Integrative longitudinal genomic analysis of therapy-resistant and metastatic pediatric cancers.
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Abstract 1509: Longitudinal profiling of high-risk pediatric malignancies using a multiomics approach.
Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.